Is It Time To Reassess Veeva Systems (VEEV) After Its Recent Share Price Slide

• Wondering if Veeva Systems at around US$157 is starting to look attractive, or if the price still feels rich for what you are getting.
• The stock has seen sharp recent moves, with returns of 9.7% decline over 7 days, 17.2% decline over 30 days, 28.4% decline year to date, and 25.4% decline over the last year, alongside a 13.1% decline over 3 years and 43.0% decline over 5 years.
• Recent coverage of Veeva Systems has focused on its role in healthcare software and how investor expectations compare with the broader sector. This context helps explain why some investors are reassessing the balance between growth potential and risk at current price levels.
• Veeva Systems currently holds a valuation score of 5 out of 6, which sets up a closer look at traditional valuation tools like P/E multiples and discounted cash flow, as well as a more comprehensive way of thinking about value that will be covered at the end of the article.

Veeva Systems delivered -25.4% returns over the last year. See how this stacks up to the rest of the Healthcare Services industry.

Approach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes projected future cash flows and discounts them back into today’s dollars, aiming to estimate what the business might be worth right now based on those cash flows.

For Veeva Systems, the latest twelve month Free Cash Flow is about $1.39b. Analysts provide explicit forecasts out to 2031, with projected Free Cash Flow of $2.43b in that year. Beyond the first several years, Simply Wall St extrapolates the later cash flows, using a 2 Stage Free Cash Flow to Equity approach to smooth the long term assumptions.

Bringing all those projected cash flows back to today using a discount rate gives an estimated intrinsic value of about $272.51 per share. Compared with the current share price around $157, the model suggests a 42.4% discount, which points to the shares trading below this DCF estimate. As always, this hinges on the cash flow forecasts and discount rate used, so it is best viewed as one input rather than a precise answer.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 42.4%. Track this in your watchlist or portfolio, or discover 62 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Veeva Systems.

Approach 2: Veeva Systems Price vs Earnings

For a profitable company like Veeva Systems, the P/E ratio is a useful way to gauge what investors are currently paying for each dollar of earnings. A higher or lower P/E often reflects how the market is weighing the mix of growth potential and risk, so a business with stronger expected growth or perceived resilience can reasonably trade on a higher multiple than one with slower growth or higher uncertainty.

Veeva Systems currently trades on a P/E of 28.23x. This sits close to the Healthcare Services industry average P/E of 28.27x and slightly above the peer group average of 27.45x. Simply Wall St’s Fair Ratio for Veeva Systems is 28.83x, which is its proprietary estimate of what the P/E could be given factors like earnings growth, industry, profit margin, market cap and risk profile. Fair Ratio can often be more informative than a simple peer or industry comparison because it adjusts for company specific characteristics rather than assuming all businesses in a sector deserve the same multiple.

With the current P/E of 28.23x compared with a Fair Ratio of 28.83x, Veeva Systems screens as slightly undervalued on this metric.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Veeva Systems Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives are that tool, letting you spell out a clear story for Veeva Systems, link that story to explicit forecasts for revenue, earnings and margins, and then connect those assumptions to a Fair Value that you can compare with the current share price. All of this is available within Simply Wall St’s Community page, where Narratives are updated automatically when new news or earnings arrive. For example, one investor might build a Veeva Systems Narrative around AI agents, subscription resilience and a Fair Value near the more optimistic US$380.0 view. Another might focus on competitive risk, CRM concentration and a Fair Value closer to the more cautious US$190.0. Seeing those side by side helps you decide whether the current price around US$157 looks cheap, expensive or close enough to your own view to act on.

Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com